Profiles

Keywords
Last Name
Institution

John Somberg

TitleProfessor
InstitutionRush University, Rush Medical College
DepartmentInternal Medicine, Division of Cardiology
Address
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 7103311250.


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Milan DJ, Saul JP, Somberg JC, Molnar J. Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis. Cardiology. 2017; 136(1):52-60. PMID: 27554842.
      View in: PubMed
    2. Somberg J, Molnar J. Adverse Reactions of Amiodarone on the Thyroid. Cardiology. 2016; 134(3):364-5. PMID: 27100465.
      View in: PubMed
    3. Somberg J, Molnar J. Sotalol versus Amiodarone in Treatment of Atrial Fibrillation. J Atr Fibrillation. 2016 Feb-Mar; 8(5):1359. PMID: 27909477.
      View in: PubMed
    4. Somberg J. Let us regulate pharmaceuticals: here we go again. Am J Ther. 2015 Nov-Dec; 22(6):409-10. PMID: 26539781.
      View in: PubMed
    5. Somberg J. Signing off. Am J Ther. 2015 Nov-Dec; 22(6):411. PMID: 26539782.
      View in: PubMed
    6. Somberg JC, Molnar J. Retrospective Evaluation on the Analgesic Activities of 2 Compounded Topical Creams and Voltaren Gel in Chronic Noncancer Pain. Am J Ther. 2015 Sep-Oct; 22(5):342-9. PMID: 26352120.
      View in: PubMed
    7. Somberg J. Angiotensin-Neprilysin Combinations Marketing Poly or Therapeutic Optimization. Am J Ther. 2015 Sep-Oct; 22(5):321. PMID: 26349018.
      View in: PubMed
    8. Molnar J, Somberg JC. Evaluation of the Effects of Different Energy Drinks and Coffee on Endothelial Function. Am J Cardiol. 2015 Nov 01; 116(9):1457-60. PMID: 26341184.
      View in: PubMed
    9. Somberg J. The Need for Stimulation. Am J Ther. 2015 Jul-Aug; 22(4):243. PMID: 26163821.
      View in: PubMed
    10. Molnar J, Somberg JC. A Rapid Method to Evaluate Cardiac Repolarization Changes: The Effect of Two Coffee Strengths on the QT Interval. Cardiology. 2015; 131(3):203-8. PMID: 25997417.
      View in: PubMed
    11. Somberg JC, Molnar J. Retrospective Study on the Analgesic Activity of a Topical (TT-CTAC) Cream in Patients With Diabetic Neuropathy and Other Chronic Pain Conditions. Am J Ther. 2015 May-Jun; 22(3):214-21. PMID: 25859821.
      View in: PubMed
    12. Somberg J, Molnar J. Lesson to be learned from the renal denervation trials. Am J Ther. 2015 May-Jun; 22(3):167-70. PMID: 25943389.
      View in: PubMed
    13. Somberg J. Computerization in medicine. Am J Ther. 2015 Mar-Apr; 22(2):89. PMID: 25734589.
      View in: PubMed
    14. Somberg JC. The new year. Am J Ther. 2015 Jan-Feb; 22(1):1. PMID: 25563561.
      View in: PubMed
    15. Somberg JC. The failing Ebola policy. Am J Ther. 2014 Nov-Dec; 21(6):441. PMID: 25373311.
      View in: PubMed
    16. Somberg JC. Digoxin therapy for atrial fibrillation in the twenty-first century. Am J Ther. 2014 Sep-Oct; 21(5):325-6. PMID: 25207980.
      View in: PubMed
    17. Somberg J. OUS results, clinical studies and therapeutic innovation in America. Am J Ther. 2014 Jul-Aug; 21(4):233. PMID: 25007241.
      View in: PubMed
    18. Somberg J. International vs. hospital acquired infection. Am J Ther. 2014 May-Jun; 21(3):141. PMID: 24813977.
      View in: PubMed
    19. Somberg J. Courts, patents, litigation & patient care. Am J Ther. 2014 May-Jun; 21(3):142. PMID: 24813978.
      View in: PubMed
    20. Somberg JC, McEwen P, Molnar J. Assessment of cardiovascular and noncardiovascular medical device recalls. Am J Cardiol. 2014 Jun 01; 113(11):1899-903. PMID: 24837271.
      View in: PubMed
    21. Somberg J. Clinical trials and their surprises. Am J Ther. 2014 Mar-Apr; 21(2):67. PMID: 24598172.
      View in: PubMed
    22. Somberg JC. Guidelines for a new year. Am J Ther. 2014 Jan-Feb; 21(1):1. PMID: 24401701.
      View in: PubMed
    23. Somberg J. The conflict of interest charade. Am J Ther. 2013 Nov-Dec; 20(6):591. PMID: 24247032.
      View in: PubMed
    24. Somberg J. Health care in turmoil. Am J Ther. 2013 Sep-Oct; 20(5):459. PMID: 24670782.
      View in: PubMed
    25. Somberg J. The Supremes got it right. Am J Ther. 2013 Jul-Aug; 20(4):315. PMID: 23838630.
      View in: PubMed
    26. Somberg JC. A perspective on the support of scientific research. Am J Ther. 2013 May-Jun; 20(3):231. PMID: 23656965.
      View in: PubMed
    27. Somberg J, Molnar J. The dark side of implantable cardioverter defibrillator therapy. Cardiology. 2013; 124(4):213-5. PMID: 23548790.
      View in: PubMed
    28. Somberg JC. The cart before the horse. Am J Ther. 2013 Mar-Apr; 20(2):127. PMID: 23466617.
      View in: PubMed
    29. Somberg JC. Conflating the approval process and clinical research with pharmacoeconomic evaluation. Am J Ther. 2013 Jan; 20(1):1. PMID: 23299228.
      View in: PubMed
    30. Somberg JC. Proposed accelerated FDA approvals for special medical use. Am J Ther. 2012 Nov; 19(6):393-4. PMID: 23154227.
      View in: PubMed
    31. Somberg JC. Making America more competitive: a paradigm shift in drug and device development. Am J Ther. 2012 Sep; 19(5):315-6. PMID: 22964557.
      View in: PubMed
    32. Somberg JC. The human microbiome and therapeutics. Am J Ther. 2012 Jul; 19(4):247. PMID: 22772032.
      View in: PubMed
    33. Somberg J. Is there an imperative for generic profiling to hasten the age of personalized medicine. Am J Ther. 2012 May; 19(3):163. PMID: 22565850.
      View in: PubMed
    34. Somberg JC. Drug shortages and ensuring the U.S. supply of needed pharmaceuticals. Am J Ther. 2012 Mar; 19(2):65. PMID: 22394999.
      View in: PubMed
    35. Somberg J. Guidelines or 10 commandments. Am J Ther. 2012 Jan; 19(1):1. PMID: 22227614.
      View in: PubMed
    36. Somberg J. Drug and device trials: should we ask more. Am J Ther. 2011 Nov; 18(6):435. PMID: 22072094.
      View in: PubMed
    37. Somberg JC. The impact of comorbidities on stroke prophylaxis strategies in atrial fibrillation patients. Am J Ther. 2011 Nov; 18(6):510-7. PMID: 22072096.
      View in: PubMed
    38. Somberg JC. The device development pinata. Am J Ther. 2011 Sep; 18(5):339. PMID: 21912221.
      View in: PubMed
    39. Somberg JC. Are we facilitating therapeutic innovation? Am J Ther. 2011 Jul; 18(4):279. PMID: 21743303.
      View in: PubMed
    40. Somberg JC. Has the food and drug administration changed the drug approval process? Am J Ther. 2011 May; 18(3):179. PMID: 21566467.
      View in: PubMed
    41. Somberg JC, Preston RA, Ranade V, Cvetanovic I, Molnar J. Gender differences in cardiac repolarization following intravenous sotalol administration. J Cardiovasc Pharmacol Ther. 2012 Mar; 17(1):86-92. PMID: 21527783.
      View in: PubMed
    42. Somberg JC. Have we maxed out on new therapies. Am J Ther. 2011 Mar-Apr; 18(2):91. PMID: 21394000.
      View in: PubMed
    43. Somberg JC. Inappropriate attack on device development. Am J Ther. 2011 Mar-Apr; 18(2):91. PMID: 21393999.
      View in: PubMed
    44. Somberg JC. From therapeutic nihilism to therapeutic success. Am J Ther. 2011 Jan; 18(1):1. PMID: 22614049.
      View in: PubMed
    45. Somberg JC. Unfinished business in health care reform. Am J Ther. 2011 Jan; 18(1):1. PMID: 22614048.
      View in: PubMed
    46. Somberg JC. The Food and Drug Administration's paternalism. Am J Ther. 2010 Nov-Dec; 17(6):533-4. PMID: 21060255.
      View in: PubMed
    47. Somberg JC. The midodrine withdrawal. Am J Ther. 2010 Sep-Oct; 17(5):445. PMID: 20844343.
      View in: PubMed
    48. Somberg JC, Preston RA, Ranade V, Molnar J. QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol. Cardiology. 2010; 116(3):219-25. PMID: 20693799.
      View in: PubMed
    49. Somberg JC, Preston RA, Ranade V, Molnar J. Developing a safe intravenous sotalol dosing regimen. Am J Ther. 2010 Jul-Aug; 17(4):365-72. PMID: 20562595.
      View in: PubMed
    50. Somberg J. Device safety and effectiveness. Am J Ther. 2010 Jul-Aug; 17(4):357. PMID: 20634652.
      View in: PubMed
    51. Somberg J. Composite end points, black box warnings, and allegations of bias. Am J Ther. 2010 May-Jun; 17(3):233. PMID: 20479575.
      View in: PubMed
    52. Somberg JC. Is the device development process adequate. Am J Ther. 2010 Mar-Apr; 17(2):123-4. PMID: 20305398.
      View in: PubMed
    53. Somberg J, Cherubini A, Lowenthal DT, Paran E, Mecocci P, Williams LS, Senin U, Hahr AJ, Molitch ME, Cheng JW, Frishman WH, Aronow WS. Topics in clinical pharmacology: cardiovascular and diabetes mellitus. Dis Mon. 2010 Mar; 56(3):105-79. PMID: 20189498.
      View in: PubMed
    54. Somberg JC. The hubris of science: defending the scientific process from political agendas. Am J Ther. 2010 Jan-Feb; 17(1):1. PMID: 20090430.
      View in: PubMed
    55. Somberg JC. Medical isotope shortages. Am J Ther. 2009 Sep-Oct; 16(5):378. PMID: 19955856.
      View in: PubMed
    56. Somberg JC. New advances and new questions in cardiovascular therapeutics. Am J Ther. 2009 Sep-Oct; 16(5):375-7. PMID: 19955855.
      View in: PubMed
    57. Somberg J. Health care reform. Am J Ther. 2009 Jul-Aug; 16(4):281-2. PMID: 19617718.
      View in: PubMed
    58. Somberg J. Supporting therapeutic innovation. Am J Ther. 2009 May-Jun; 16(3):203. PMID: 19454858.
      View in: PubMed
    59. Molnar J, Somberg JC. Neurocardiogenic syncope. Cardiology. 2009; 114(1):47-9. PMID: 19365114.
      View in: PubMed
    60. Somberg JC. The extrapolation of study results in the device approval process. Am J Cardiol. 2009 May 01; 103(9):1323-4. PMID: 19406280.
      View in: PubMed
    61. Somberg JC. The stimulus package and medical therapeutics. Am J Ther. 2009 Mar-Apr; 16(2):105. PMID: 19262356.
      View in: PubMed
    62. Molnar J, Somberg JC. The dynamics of QT dispersion. Cardiology. 2009; 113(3):169-71. PMID: 19136824.
      View in: PubMed
    63. Somberg JC, Molnar J. The management of acute heart failure and diuretic therapy. Am J Ther. 2009 Jan-Feb; 16(1):93-7. PMID: 19142155.
      View in: PubMed
    64. Somberg JC. Evidence based or mechanism based therapeutics. Am J Ther. 2009 Jan-Feb; 16(1):1. PMID: 19142154.
      View in: PubMed
    65. Somberg JC, Molnar J. Therapeutic approaches to the treatment of edema and ascites: the use of diuretics. Am J Ther. 2009 Jan-Feb; 16(1):98-101. PMID: 19142158.
      View in: PubMed
    66. Molnar J, Somberg JC. The clinical pharmacology of ethacrynic acid. Am J Ther. 2009 Jan-Feb; 16(1):86-92. PMID: 19142159.
      View in: PubMed
    67. Somberg JC, Molnar J. The pleiotropic effects of ethacrynic acid. Am J Ther. 2009 Jan-Feb; 16(1):102-4. PMID: 19142157.
      View in: PubMed
    68. Lin C, Somberg T, Molnar J, Somberg J. The effects of chiral isolates of methadone on the cardiac potassium channel IKr. Cardiology. 2009; 113(1):59-65. PMID: 18984955.
      View in: PubMed
    69. Somberg J. The drug eluting stent challenge. Am J Ther. 2008 Nov-Dec; 15(6):505. PMID: 19127131.
      View in: PubMed
    70. Somberg J. Licensing to prescribe. Am J Ther. 2008 Sep-Oct; 15(5):417-8. PMID: 18806515.
      View in: PubMed
    71. Molnar J, Somberg JC. QT dispersion: still a useful measurement. Cardiology. 2009; 112(3):165-7. PMID: 18654080.
      View in: PubMed
    72. Somberg JC. The sins of ghostwriting. Am J Ther. 2008 Jul-Aug; 15(4):297-8. PMID: 18645328.
      View in: PubMed
    73. Nada A, Baxter S, Loraas E, Somberg JC. Incidence and predictors of screen failures due to positive urine tests for alcohol, drugs of abuse, and cotinine among normal healthy research volunteers (NHRVs): analysis of data from 687 NHRVs screened at a large clinical pharmacology unit in the United States. Am J Ther. 2008 May-Jun; 15(3):214-20. PMID: 18496258.
      View in: PubMed
    74. Somberg JC, Molnar J. The cholesterol hypothesis: questioned? Am J Ther. 2008 May-Jun; 15(3):292-5. PMID: 18496268.
      View in: PubMed
    75. Somberg JC. Securing the US pharmaceutical supply. Am J Ther. 2008 May-Jun; 15(3):197. PMID: 18496255.
      View in: PubMed
    76. Somberg J, Molnar J. Ventricular repolarization spectra. Cardiology. 2008; 111(3):207-8. PMID: 18434727.
      View in: PubMed
    77. Somberg JC. Flecainide: safety and efficacy. Cardiology. 2008; 111(2):82. PMID: 18376117.
      View in: PubMed
    78. Somberg J. FDA user fees and innovation. Am J Ther. 2008 Mar-Apr; 15(2):97. PMID: 18356626.
      View in: PubMed
    79. Somberg J. Therapeutic hangups. Am J Ther. 2008 Jan-Feb; 15(1):1. PMID: 18223345.
      View in: PubMed
    80. Lin C, Ke X, Ranade V, Somberg J. The additive effects of the active component of grapefruit juice (naringenin) and antiarrhythmic drugs on HERG inhibition. Cardiology. 2008; 110(3):145-52. PMID: 18057881.
      View in: PubMed
    81. Lin C, Ke X, Ranade V, Somberg J. Extracellular acidification and hyperkalemia induce changes in HERG inhibition by ibutilide. Cardiology. 2008; 110(3):209-16. PMID: 18057887.
      View in: PubMed
    82. Nada A, Somberg J. First-in-Man (FIM) clinical trials post-TeGenero: a review of the impact of the TeGenero trial on the design, conduct, and ethics of FIM trials. Am J Ther. 2007 Nov-Dec; 14(6):594-604. PMID: 18090886.
      View in: PubMed
    83. Somberg J. Screening drugs for QT prolongation. Am J Ther. 2007 Sep-Oct; 14(5):419-20. PMID: 17890927.
      View in: PubMed
    84. Somberg J. Mandatory post marketing studies. Am J Ther. 2007 Jul-Aug; 14(4):321. PMID: 17667203.
      View in: PubMed
    85. Somberg J. Patent foramen ovale closure devices: thoughts from the circulatory device advisory panel. Am J Cardiol. 2007 Sep 01; 100(5):905-6. PMID: 17719343.
      View in: PubMed
    86. Somberg J. Biologic generics. Am J Ther. 2007 May-Jun; 14(3):230. PMID: 17515694.
      View in: PubMed
    87. Cvetanovic I, Lin C, Ranade V, Keshavarzian A, Somberg J. The effects of quinidine and its chiral isolates on erg-1sm potassium current and correlation with gastrointestinal augmentation. Am J Ther. 2007 May-Jun; 14(3):269-76. PMID: 17515703.
      View in: PubMed
    88. Somberg J. Guilt by association. Am J Ther. 2007 May-Jun; 14(3):229-30. PMID: 17515693.
      View in: PubMed
    89. Somberg J. The drug safety review process. Am J Ther. 2007 Mar-Apr; 14(2):119. PMID: 17414577.
      View in: PubMed
    90. Somberg J, Weinberger J. Late stent thrombosis: problem or not? Am J Cardiol. 2007 Apr 01; 99(7):1020-3. PMID: 17398205.
      View in: PubMed
    91. Somberg J. The report of the Institute of Medicine on drug safety. Am J Ther. 2007 Jan-Feb; 14(1):1-2. PMID: 17303967.
      View in: PubMed
    92. Somberg J. The hypertension peril and drug development. Am J Ther. 2007 Jan-Feb; 14(1):2. PMID: 17303968.
      View in: PubMed
    93. Cvetanovic I, Ranade V, Molnar J, Whelton A, Somberg J. The evaluation of the diuretic action of parenteral formulations of metolazone. Am J Ther. 2007 Jan-Feb; 14(1):25-9. PMID: 17303972.
      View in: PubMed
    94. Somberg J. Physician specific prescribing information. Am J Ther. 2006 Nov-Dec; 13(6):465. PMID: 17122524.
      View in: PubMed
    95. Lin C, Ke X, Cvetanovic I, Ranade V, Somberg J. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents. Cardiology. 2007; 108(1):18-27. PMID: 16960444.
      View in: PubMed
    96. Somberg J. Off-label promotion. Am J Ther. 2006 Sep-Oct; 13(5):387. PMID: 16988530.
      View in: PubMed
    97. Somberg J. Surrogate endpoints and drug approval. Am J Ther. 2006 Sep-Oct; 13(5):388. PMID: 16988531.
      View in: PubMed
    98. Somberg J. Genetic drug targeting. Am J Ther. 2006 Jul-Aug; 13(4):289-90. PMID: 16858160.
      View in: PubMed
    99. Molnar J, Ranade V, Cvetanovic I, Molnar Z, Somberg JC. Evaluation of a 12-lead digital Holter system for 24-hour QT interval assessment. Cardiology. 2006; 106(4):224-32. PMID: 16685129.
      View in: PubMed
    100. Somberg JC. Risk assessment, drug approval, and liability. Am J Ther. 2006 May-Jun; 13(3):181-2. PMID: 16772756.
      View in: PubMed
    101. Somberg JC. Pharmaceutical companies and medical therapeutics education. Am J Ther. 2006 Mar-Apr; 13(2):93. PMID: 16645422.
      View in: PubMed
    102. Somberg J, Molnar J. Letter from Konstantinos P. Letsas et al. - invited editorial comment. Cardiology. 2006; 105(3):148. PMID: 16449813.
      View in: PubMed
    103. Cvetanovic I, Ranade V, Lin C, Somberg J. The differential antibacterial and gastrointestinal effects of erythromycin and its chiral isolates. Am J Ther. 2006 Jan-Feb; 13(1):48-56. PMID: 16428922.
      View in: PubMed
    104. Somberg JC. An opportunity to distance the FDA from Washington politics. Am J Ther. 2005 Nov-Dec; 12(6):475. PMID: 16280638.
      View in: PubMed
    105. Ranade VV, Somberg JC. Chiral cardiovascular drugs: an overview. Am J Ther. 2005 Sep-Oct; 12(5):439-59. PMID: 16148430.
      View in: PubMed
    106. Somberg JC. Nesiritide: the wrong controversy. Am J Ther. 2005 Sep-Oct; 12(5):377-8. PMID: 16148421.
      View in: PubMed
    107. Lin C, Cvetanovic I, Ke X, Ranade V, Somberg J. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels. Am J Ther. 2005 Jul-Aug; 12(4):328-36. PMID: 16041196.
      View in: PubMed
    108. Somberg J. Intellectual property. Am J Ther. 2005 Jul-Aug; 12(4):285. PMID: 16041189.
      View in: PubMed
    109. Somberg JC. The new drug evaluation process: risk benefit ratio. Am J Ther. 2005 May-Jun; 12(3):199-200. PMID: 15891261.
      View in: PubMed
    110. Somberg JC, Cao W, Cvetanovic I, Ranade VV, Molnar J. The effect of magnesium sulfate on action potential duration and cardiac arrhythmias. Am J Ther. 2005 May-Jun; 12(3):218-22. PMID: 15891264.
      View in: PubMed
    111. Lin C, Ke X, Cvetanovic I, Ranade V, Somberg J. The influence of extracellular acidosis on the effect of IKr blockers. J Cardiovasc Pharmacol Ther. 2005 Mar; 10(1):67-76. PMID: 15821840.
      View in: PubMed
    112. Somberg J. Lessons learned from the COX-2 advisory hearings. Am J Ther. 2005 Mar-Apr; 12(2):105. PMID: 15767826.
      View in: PubMed
    113. Somberg J. The provisional approval step. Am J Ther. 2005 Jan-Feb; 12(1):1-2. PMID: 15662285.
      View in: PubMed
    114. Somberg JC, Cao W, Cvetanovic I, Ranade V, Molnar J. Pharmacology and toxicology of a new aqueous formulation of intravenous amiodarone (Amio-Aqueous) compared with Cordarone IV. Am J Ther. 2005 Jan-Feb; 12(1):9-16. PMID: 15662287.
      View in: PubMed
    115. Somberg JC, Molnar J. The pharmacologic treatment of heart failure. Am J Ther. 2004 Nov-Dec; 11(6):480-8. PMID: 15543089.
      View in: PubMed
    116. Somberg J. The politics of therapeutics. Am J Ther. 2004 Nov-Dec; 11(6):422. PMID: 15543080.
      View in: PubMed
    117. Somberg J. Drug trial registries. Am J Ther. 2004 Sep-Oct; 11(5):327. PMID: 15356427.
      View in: PubMed
    118. Somberg JC, Cvetanovic I, Ranade V, Molnar J. Comparative effects of rapid bolus administration of aqueous amiodarone versus 10-minute cordarone I.v. infusion on mean arterial blood pressure in conscious dogs. Cardiovasc Drugs Ther. 2004 Sep; 18(5):345-51. PMID: 15717136.
      View in: PubMed
    119. Somberg J. What is a journal. Am J Ther. 2004 Jul-Aug; 11(4):243. PMID: 15266214.
      View in: PubMed
    120. Somberg J. Obesity therapeutics in the shadows: editorial. Am J Ther. 2004 May-Jun; 11(3):155. PMID: 15133528.
      View in: PubMed
    121. Somberg JC, Timar S, Bailin SJ, Lakatos F, Haffajee CI, Tarjan J, Paladino WP, Sarosi I, Kerin NZ, Borbola J, Bridges DE, Molnar J. Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone. Am J Cardiol. 2004 Mar 01; 93(5):576-81. PMID: 14996582.
      View in: PubMed
    122. Somberg J. Who is teaching pharmacology. Am J Ther. 2004 Mar-Apr; 11(2):83-4. PMID: 14999358.
      View in: PubMed
    123. Somberg J. Should statins go OTC. Am J Ther. 2004 Jan-Feb; 11(1):1-2. PMID: 14704588.
      View in: PubMed
    124. Cobleigh M, Somberg JC. A case of herceptin cardiotoxicity. Am J Ther. 2004 Jan-Feb; 11(1):74-6. PMID: 14704598.
      View in: PubMed
    125. Somberg J. Therapeutics 2004. Am J Ther. 2004 Jan-Feb; 11(1):1. PMID: 14704587.
      View in: PubMed
    126. Somberg JC, Torres V, Keren G, Butler B, Tepper D, Kleinbaum H, Molnar J. Enhancement of myocardial vulnerability by atrial fibrillation. Am J Ther. 2004 Jan-Feb; 11(1):33-43. PMID: 14704594.
      View in: PubMed
    127. Somberg J. Therapeutics, drug pricing and innovation. Am J Ther. 2003 Nov-Dec; 10(6):381. PMID: 14624273.
      View in: PubMed
    128. Somberg JC, Molnar J. The quest for an aqueous amiodarone. Am J Ther. 2003 Nov-Dec; 10(6):458-61. PMID: 14624286.
      View in: PubMed
    129. Somberg J. Clinical trials registries. Am J Ther. 2003 Sep-Oct; 10(5):309-10. PMID: 12975713.
      View in: PubMed
    130. Somberg J. Biomarker and surrogate endpoints. Am J Ther. 2003 Jul-Aug; 10(4):239-40. PMID: 12845385.
      View in: PubMed
    131. Somberg JC. SARS challenges therapeutics. Am J Ther. 2003 May-Jun; 10(3):161. PMID: 12756421.
      View in: PubMed
    132. Somberg JC. Hypertension therapeutics in turmoil. Am J Ther. 2003 Mar-Apr; 10(2):81-2. PMID: 12629584.
      View in: PubMed
    133. Somberg JC. Pediatric drug development. Am J Ther. 2003 Jan-Feb; 10(1):2. PMID: 12522512.
      View in: PubMed
    134. Somberg JC. Clinical therapeutic conference. Am J Ther. 2003 Jan-Feb; 10(1):78-80. PMID: 12522528.
      View in: PubMed
    135. Somberg JC. Free exchange of ideas. Am J Ther. 2003 Jan-Feb; 10(1):1. PMID: 12522511.
      View in: PubMed
    136. Najeed SA, Khan IA, Molnar J, Somberg JC. Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect. Am J Cardiol. 2002 Nov 15; 90(10):1103-6. PMID: 12423711.
      View in: PubMed
    137. Somberg JC. Biologic problems. Am J Ther. 2002 Nov-Dec; 9(6):471. PMID: 12424501.
      View in: PubMed
    138. Somberg JC. Arrhythmia therapy. Am J Ther. 2002 Nov-Dec; 9(6):537-42. PMID: 12424515.
      View in: PubMed
    139. Gallik DM, Singer I, Meissner MD, Molnar J, Somberg JC. Hemodynamic and surface electrocardiographic effects of a new aqueous formulation of intravenous amiodarone. Am J Cardiol. 2002 Nov 01; 90(9):964-8. PMID: 12398963.
      View in: PubMed
    140. Somberg JC, Bailin SJ, Haffajee CI, Paladino WP, Kerin NZ, Bridges D, Timar S, Molnar J. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. Am J Cardiol. 2002 Oct 15; 90(8):853-9. PMID: 12372573.
      View in: PubMed
    141. Somberg JC. Restricting physician prescribing. Am J Ther. 2002 Sep-Oct; 9(5):369. PMID: 12237726.
      View in: PubMed
    142. Somberg JC. Genetic polymorphisms. Am J Ther. 2002 Jul-Aug; 9(4):271. PMID: 12115013.
      View in: PubMed
    143. Somberg JC. Old drugs, new bottles, therapeutic advantage? Am J Ther. 2002 Jul-Aug; 9(4):273-4. PMID: 12115014.
      View in: PubMed
    144. Somberg JC. Clinical research oversight. Am J Ther. 2002 Mar-Apr; 9(2):85. PMID: 11897921.
      View in: PubMed
    145. Somberg JC. The generic conundrum. Am J Ther. 2002 Mar-Apr; 9(2):87-8. PMID: 11897922.
      View in: PubMed
    146. Somberg JC, Molnar J. Usefulness of QT dispersion as an electrocardiographically derived index. Am J Cardiol. 2002 Feb 01; 89(3):291-4. PMID: 11809431.
      View in: PubMed
    147. Somberg JC. Bioterrorism 2002. Am J Ther. 2002 Jan-Feb; 9(1):3. PMID: 11782812.
      View in: PubMed
    148. Ranade V, Somberg JC. Rapid determination of partition coefficients between n-octanol/water for cardiovascular therapies. Am J Ther. 2002 Jan-Feb; 9(1):19-24. PMID: 11782815.
      View in: PubMed
    149. Somberg J, Molnar J. Atrial fibrillation and valve disease. Adv Cardiol. 2002; 39:39-48. PMID: 12060922.
      View in: PubMed
    150. Somberg JC. American Journal of Therapeutics. Am J Ther. 2002 Jan-Feb; 9(1):1. PMID: 11910214.
      View in: PubMed
    151. Somberg JC. A new therapeutic millennium [correction of millenium]. Am J Ther. 2001 Nov-Dec; 8(6):385-6. PMID: 11704776.
      View in: PubMed
    152. Somberg JC. A challenge to America. Am J Ther. 2001 Nov-Dec; 8(6):383. PMID: 11704775.
      View in: PubMed
    153. Somberg JC. Stem-cell research. Am J Ther. 2001 Sep-Oct; 8(5):307. PMID: 11550069.
      View in: PubMed
    154. Ranade VV, Somberg JC. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther. 2001 Sep-Oct; 8(5):345-57. PMID: 11550076.
      View in: PubMed
    155. Somberg JC. Class effects of pharmaceuticals and therapeutic interchangeability. Am J Ther. 2001 Jul-Aug; 8(4):221-2. PMID: 11441318.
      View in: PubMed
    156. Somberg JC. Do we need to accredit clinical research? Am J Ther. 2001 Jul-Aug; 8(4):223-4. PMID: 11441319.
      View in: PubMed
    157. Somberg JC. Proposed product labeling changes: does it really matter? Am J Ther. 2001 May-Jun; 8(3):145-6. PMID: 11344380.
      View in: PubMed
    158. Yelamanchi VP, Molnar J, Ranade V, Somberg JC. Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography. Am J Ther. 2001 Mar-Apr; 8(2):117-22. PMID: 11304665.
      View in: PubMed
    159. Somberg JC. Pediatric exclusivity and genericizing pharmaceuticals. Am J Ther. 2001 Mar-Apr; 8(2):79-80. PMID: 11304660.
      View in: PubMed
    160. Somberg JC. Are we overregulated? Am J Ther. 2001 Jan-Feb; 8(1):1-2. PMID: 11304650.
      View in: PubMed
    161. Somberg JC. Clinical therapeutic conference: congestive heart failure therapy. Am J Ther. 2001 Jan-Feb; 8(1):65-72. PMID: 11304659.
      View in: PubMed
    162. Somberg JC. The cost of therapy. Am J Ther. 2000 Nov; 7(6):343-4. PMID: 11304640.
      View in: PubMed
    163. Somberg JC. Sudden death in athletes. Am J Ther. 2000 Nov; 7(6):399-403. PMID: 11304649.
      View in: PubMed
    164. Somberg JC. Is clinical research oversight adequate in the United States? Am J Ther. 2000 Sep; 7(5):283-4. PMID: 11317171.
      View in: PubMed
    165. Clark CT, Resenblatt R, Somberg JC. Neurocardiogenic syncope with Addison's disease. Am J Ther. 2000 Sep; 7(5):328-31. PMID: 11317182.
      View in: PubMed
    166. Somberg JC. A choice, not an echo. Am J Ther. 2000 Sep; 7(5):281. PMID: 11317170.
      View in: PubMed
    167. Somberg JC. Adverse drug reaction reporting. Am J Ther. 2000 Aug; 7(4):227-8. PMID: 11486155.
      View in: PubMed
    168. Somberg JC. Is the evidence right in evidence-based practice? Am J Ther. 2000 May; 7(3):149-50. PMID: 11317162.
      View in: PubMed
    169. Wolf ME, Ranade V, Molnar J, Somberg J, Mosnaim AD. Hypercalcemia, arrhythmia, and mood stabilizers. J Clin Psychopharmacol. 2000 Apr; 20(2):260-4. PMID: 10770468.
      View in: PubMed
    170. Somberg JC. What's gone wrong with clinical research. Am J Ther. 2000 Mar; 7(2):49-50. PMID: 11319572.
      View in: PubMed
    171. Somberg JC. A federal solution a regulation for all. Am J Ther. 2000 Jan; 7(1):1-2. PMID: 11319566.
      View in: PubMed
    172. Somberg JC. Medical judgment and therapeutics. Am J Ther. 1999 Nov; 6(6):291-2. PMID: 11329111.
      View in: PubMed
    173. Ranade V, Molnar J, Khokher T, Agarwal A, Mosnaim A, Somberg JC. Effect of angiotensin-converting enzyme therapy on QT interval dispersion. Am J Ther. 1999 Sep; 6(5):257-61. PMID: 11329107.
      View in: PubMed
    174. Somberg JC. Reorganizing the flow of scientific information: is the age of electronic journalism here? Am J Ther. 1999 Sep; 6(5):235-6. PMID: 11329103.
      View in: PubMed
    175. Somberg JC. International symposium on drug development. Am J Ther. 1999 Sep; 6(5):289. PMID: 11329110.
      View in: PubMed
    176. Somberg JC. Biomarkers and surrogate endpoints. Am J Ther. 1999 Jul; 6(4):179-80. PMID: 11329094.
      View in: PubMed
    177. Somberg JC, Borer JS. Advances in cardiovascular pharmacology: protocol design and methodology--the US regulatory process. Am J Ther. 1999 May; 6(3):175-8. PMID: 10423661.
      View in: PubMed
    178. Wolf ME, Moffat M, Ranade V, Somberg JC, Lehrer E, Mosnaim AD. Lithium, hypercalcemia, and arrhythmia. J Clin Psychopharmacol. 1998 Oct; 18(5):420-3. PMID: 9790163.
      View in: PubMed
    179. Somberg JC. Reactions to prescribed drugs kill thousands annually. Am J Ther. 1998 May; 5(3):133. PMID: 10660364.
      View in: PubMed
    180. Tarabey R, Sukenik D, Molnar J, Somberg JC. Effect of intracoronary balloon inflation at percutaneous transluminal coronary angioplasty on QT dispersion. Am Heart J. 1998 Mar; 135(3):519-22. PMID: 9506339.
      View in: PubMed
    181. Schulze-Bahr E, Wang Q, Wedekind H, Haverkamp W, Chen Q, Sun Y, Rubie C, Hördt M, Towbin JA, Borggrefe M, Assmann G, Qu X, Somberg JC, Breithardt G, Oberti C, Funke H. KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet. 1997 Nov; 17(3):267-8. PMID: 9354783.
      View in: PubMed
    182. Somberg JC, Yelamanchi V, Molnar J, Aschermann M, Bernink PJ, Caspi A, Marmor A, Rabinowitz B, Reisin L, Ruzyllo W. Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil Investigators. Am J Ther. 1997 Nov-Dec; 4(11-12):401-4. PMID: 10423637.
      View in: PubMed
    183. Molnar J, Rosenthal JE, Weiss JS, Somberg JC. QT interval dispersion in healthy subjects and survivors of sudden cardiac death: circadian variation in a twenty-four-hour assessment. Am J Cardiol. 1997 May 01; 79(9):1190-3. PMID: 9164883.
      View in: PubMed
    184. Ichkhan K, Molnar J, Somberg J. Relation of left ventricular mass and QT dispersion in patients with systematic hypertension. Am J Cardiol. 1997 Feb 15; 79(4):508-11. PMID: 9052362.
      View in: PubMed
    185. Somberg JC. The Year in Review. Am J Ther. 1996 Dec; 3(12):1. PMID: 11862239.
      View in: PubMed
    186. Somberg JC. The Therapeutics of Hypertensive Emergency. Am J Ther. 1996 Nov; 3(11):741. PMID: 11862231.
      View in: PubMed
    187. Khosla S, Tarabey R, Megellas MM, Somberg JC. Approaches to Intravenous Nitroglycerin Therapy. Am J Ther. 1996 Nov; 3(11):766-770. PMID: 11862236.
      View in: PubMed
    188. Somberg JC. Rational therapeutics: dose titration and monotherapy in clinical practice. Am J Ther. 1996 Oct; 3(10):671. PMID: 11862221.
      View in: PubMed
    189. Khosla S, Somberg JC. Gender differences in drug therapy. Am J Ther. 1996 Oct; 3(10):735-9. PMID: 11862230.
      View in: PubMed
    190. Somberg JC. The FDA and Software. Am J Ther. 1996 Sep; 3(9):609-610. PMID: 11862299.
      View in: PubMed
    191. Somberg JC, Ichkhan K. Clinical Therapeutic Conference: Therapeutic Considerations in Atrial Fibrillation Management. Am J Ther. 1996 Sep; 3(9):658-660. PMID: 11862307.
      View in: PubMed
    192. Somberg JC. The Commercialization of Research. Am J Ther. 1996 Aug; 3(8):551. PMID: 11862289.
      View in: PubMed
    193. Somberg JC. Changing the Regulatory Process. Am J Ther. 1996 Jul; 3(7):477-478. PMID: 11862277.
      View in: PubMed
    194. Somberg JC. Histamine and Antihistamines: Clinical Pharmacology for the Practicing Physician. Am J Ther. 1996 Jul; 3(7):521-524. PMID: 11862284.
      View in: PubMed
    195. Somberg JC. Smoking, Smoking Cessation, and Regulation. Am J Ther. 1996 May; 3(5):333. PMID: 11862268.
      View in: PubMed
    196. Khosla S, Hentschel J, Somberg JC. Smoking Cessation Strategies. Am J Ther. 1996 May; 3(5):342-347. PMID: 11862270.
      View in: PubMed
    197. Khosla S, Duggal C, Somberg JC. Successful heart failure therapy is effective antiarrhythmia therapy. Am Heart J. 1996 May; 131(5):1048-50. PMID: 8615298.
      View in: PubMed
    198. Somberg JC. The Cancer Myth. Am J Ther. 1996 Apr; 3(4):259-260. PMID: 11862258.
      View in: PubMed
    199. Somberg JC. Nonphysician Prescribing. Am J Ther. 1996 Mar; 3(3):177. PMID: 11862247.
      View in: PubMed
    200. Somberg JC. Revisiting Adverse Drug Reactions. Am J Ther. 1996 Feb; 3(2):99. PMID: 11859378.
      View in: PubMed
    201. Somberg JC. Editorial: Inertia in Clinical Research. Am J Ther. 1996 Jan; 3(1):1-2. PMID: 11856990.
      View in: PubMed
    202. Somberg JC. The Promise of Chirality. Am J Ther. 1995 Dec; 2(12):909-910. PMID: 11854806.
      View in: PubMed
    203. Somberg JC. The Information Age and Therapeutics. Am J Ther. 1995 Nov; 2(11):827. PMID: 11854794.
      View in: PubMed
    204. Somberg JC. Clinical Therapeutic Conference: Thyroid Hormone Replacement in Hypothyroidism. Am J Ther. 1995 Nov; 2(11):900-905. PMID: 11854805.
      View in: PubMed
    205. Somberg JC. Off Label Indications. Am J Ther. 1995 Oct; 2(10):737-738. PMID: 11854779.
      View in: PubMed
    206. Somberg JC. Misoprostol and Eicosanoids: A New and Exciting Area of Therapeutics. Am J Ther. 1995 Sep; 2(9):589. PMID: 11854830.
      View in: PubMed
    207. Khosla S, Coutinho NB, Megellas MM, Mukherjee D, Somberg JC. Can nitroglycerin convert effort-induced angina in men into silent myocardial ischemia? Am J Cardiol. 1995 Aug 15; 76(5):337-9. PMID: 7639156.
      View in: PubMed
    208. Somberg JC. Smoking. Am J Ther. 1995 Aug; 2(8):523-524. PMID: 11854820.
      View in: PubMed
    209. Somberg JC. Clinical Therapeutic Conference: Sudden Death in a Young Athlete. Am J Ther. 1995 Aug; 2(8):581-585. PMID: 11854829.
      View in: PubMed
    210. Somberg JC. Proarrhythmia or Arrhythmogenicity. Am J Ther. 1995 Jul; 2(7):449. PMID: 11850689.
      View in: PubMed
    211. Somberg JC. A New Virus and the Adequacy of Public Health Methods. Am J Ther. 1995 Jun; 2(6):371. PMID: 11850679.
      View in: PubMed
    212. Somberg JC. Practice Guidelines, Consensus Conferences: The Pros and Cons. Am J Ther. 1995 May; 2(5):301. PMID: 11850666.
      View in: PubMed
    213. Somberg JC. Panel Discussion. Am J Ther. 1995 May; 2(5):347-358. PMID: 11850677.
      View in: PubMed
    214. Somberg JC. The Calcium Channel Blockers. Am J Ther. 1995 Apr; 2(4):231-232. PMID: 11850653.
      View in: PubMed
    215. Somberg JC. The Governmental Revolution. Am J Ther. 1995 Mar; 2(3):157. PMID: 11847545.
      View in: PubMed
    216. Somberg JC. Dismantling the FDA. Am J Ther. 1995 Feb; 2(2):79. PMID: 11847532.
      View in: PubMed
    217. Somberg JC. Editorial: Deferred Consent: Issues In Clinical Research. Am J Ther. 1995 Jan; 2(1):1. PMID: 11850639.
      View in: PubMed
    218. Somberg JC. Editorial: The Basis of Pharmaceutical Approval. Am J Ther. 1994 Dec; 1(4):253. PMID: 11835095.
      View in: PubMed
    219. Somberg JC. Clinical Therapeutic Conference. Am J Ther. 1994 Dec; 1(4):333-338. PMID: 11835108.
      View in: PubMed
    220. Somberg JC. Editorial: Therapeutics, Clinical Phamacology, Molecular Pharmacology: Have We Lost Our Academic Way? Am J Ther. 1994 Oct; 1(3):171-172. PMID: 11835083.
      View in: PubMed
    221. Somberg JC. Clinical Therapeutic Conference: Vancomycin Nephrotoxicity. Am J Ther. 1994 Oct; 1(3):245-251. PMID: 11835094.
      View in: PubMed
    222. Kerin NZ, Somberg J. Proarrhythmia: definition, risk factors, causes, treatment, and controversies. Am Heart J. 1994 Sep; 128(3):575-85. PMID: 8074022.
      View in: PubMed
    223. Somberg JC. Pharmacoeconomics: These Changing Times. Am J Ther. 1994 Aug; 1(2):105-106. PMID: 11835073.
      View in: PubMed
    224. Somberg JC. To Begin Again. Am J Ther. 1994 Jun; 1(1):3. PMID: 11835059.
      View in: PubMed
    225. Martyn R, Somberg JC, Kerin NZ. Proarrhythmia of nonantiarrhythmic drugs. Am Heart J. 1993 Jul; 126(1):201-5. PMID: 8322665.
      View in: PubMed
    226. Somberg J, Shroff G, Khosla S, Ehrenpreis S. The clinical implications of first-pass metabolism: treatment strategies for the 1990s. J Clin Pharmacol. 1993 Jul; 33(7):670-3. PMID: 8366192.
      View in: PubMed
    227. Tullo NG, Landau S, Goldman I, Coutinho N, Somberg J. A randomized comparative study of the electrophysiological and electrocardiographic effects of isradipine vs verapamil. Acta Anaesthesiol Scand Suppl. 1993; 99:43-7. PMID: 8480506.
      View in: PubMed
    228. Somberg JC. Sharing regulatory review costs. J Clin Pharmacol. 1992 Oct; 32(10):867. PMID: 1447393.
      View in: PubMed
    229. Lavie E, Gergans G, Somberg JC. A comparison of tablets with oral suspension formulation of dipyridamole in thallium myocardial imaging. J Clin Pharmacol. 1992 Jun; 32(6):546-52. PMID: 1634642.
      View in: PubMed
    230. Freedman MD, Somberg JC. Pharmacology and pharmacokinetics of amiodarone. J Clin Pharmacol. 1991 Nov; 31(11):1061-9. PMID: 1753010.
      View in: PubMed
    231. Somberg J, Kreamer J, Camba N. Amiodarone therapy guided by electrophysiologic testing: an update. J Clin Pharmacol. 1991 Nov; 31(11):1089-95. PMID: 1753014.
      View in: PubMed
    232. Kreamer JW, Zevitz M, Somberg JC. The role of electrophysiologic testing in the selection of amiodarone therapy. J Clin Pharmacol. 1989 May; 29(5):429-35. PMID: 2661602.
      View in: PubMed
    233. Somberg JC. Usefulness of electrophysiologic studies in predicting drug efficacy in patients receiving amiodarone. Am J Cardiol. 1987 Nov 15; 60(14):1218. PMID: 3687772.
      View in: PubMed
    234. Wyndham CR, Pratt CM, Mann DE, Winkle RA, Somberg J, de Maria AN, Josephson ME. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia. Am J Cardiol. 1987 Oct 16; 60(11):67F-72F. PMID: 3310588.
      View in: PubMed
    235. Somberg JC, Zanger D, Levine E, Tepper D. Encainide: a new and potent antiarrhythmic. Am Heart J. 1987 Oct; 114(4 Pt 1):826-35. PMID: 3116833.
      View in: PubMed
    236. Schwartz J, Crocker K, Wynn J, Somberg JC. The antiarrhythmic effects of d-sotalol. Am Heart J. 1987 Sep; 114(3):539-44. PMID: 3630894.
      View in: PubMed
    237. Zempol P, Aogaichi K, Butler B, Tepper D, Somberg JC. Evaluation of dosing interval and optimum dose of cibenzoline. J Clin Pharmacol. 1987 Sep; 27(9):666-72. PMID: 3680596.
      View in: PubMed
    238. Somberg JC, Tepper D, Sacher H, Schwarz J. Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide. Am Heart J. 1987 Jul; 114(1 Pt 1):18-25. PMID: 3111236.
      View in: PubMed
    239. Miura DS, Schwartz J, Laux B, Wynn J, Keefe D, Somberg JC. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia. J Clin Pharmacol. 1987 Jul; 27(7):481-6. PMID: 3654999.
      View in: PubMed
    240. Steinberg JS, Katz RJ, Somberg JC, Keefe D, Laddu AR, Burge J. Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias. Am J Cardiol. 1986 Nov 01; 58(10):1005-8. PMID: 2877563.
      View in: PubMed
    241. Anderson JL, Askins JC, Gilbert EM, Miller RH, Keefe DL, Somberg JC, Freedman RA, Haft LR, Mason JW, Lessem JN. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses. J Am Coll Cardiol. 1986 Oct; 8(4):752-62. PMID: 2428852.
      View in: PubMed
    242. Wynn J, Fingerhood M, Keefe D, Maza S, Miura D, Somberg JC. Refractory ventricular tachycardia with flecainide. Am Heart J. 1986 Jul; 112(1):174-5. PMID: 3728275.
      View in: PubMed
    243. Somberg JC, Miura D, Keefe DL. The treatment of ventricular rhythm disturbances. Am Heart J. 1986 Jun; 111(6):1162-76. PMID: 2424297.
      View in: PubMed
    244. Keefe DL, Miura D, Somberg JC. Supraventricular tachyarrhythmias: their evaluation and therapy. Am Heart J. 1986 Jun; 111(6):1150-61. PMID: 3521246.
      View in: PubMed
    245. Wynn J, Torres V, Flowers D, Mizruchi M, Keefe D, Miura D, Somberg J. Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide. Am Heart J. 1986 Apr; 111(4):632-8. PMID: 3953384.
      View in: PubMed
    246. Somberg JC, Laux B, Wynn J, Keefe D, Miura DS. Lorcainide therapy in a cardiac arrest population. Am Heart J. 1986 Apr; 111(4):648-53. PMID: 3953387.
      View in: PubMed
    247. Miura DS, Wynn J, Torres V, Laux B, Keefe D, Somberg JC. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation. Am Heart J. 1986 Apr; 111(4):661-6. PMID: 3513503.
      View in: PubMed
    248. Keefe DL, Williams S, Torres V, Flowers D, Somberg JC. Prophylactic tocainide or lidocaine in acute myocardial infarction. Am J Cardiol. 1986 Mar 01; 57(8):527-31. PMID: 3082175.
      View in: PubMed
    249. Torres V, Tepper D, Flowers D, Wynn J, Lam S, Keefe D, Miura DS, Somberg JC. QT prolongation and the antiarrhythmic efficacy of amiodarone. J Am Coll Cardiol. 1986 Jan; 7(1):142-7. PMID: 3941202.
      View in: PubMed
    250. Morganroth J, Somberg JC, Pool PE, Hsu PH, Lee IK, Durkee J, Salerno DM. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. J Am Coll Cardiol. 1986 Jan; 7(1):9-16. PMID: 3079781.
      View in: PubMed
    251. Wynn J, Miura DS, Torres V, Flowers D, Keefe D, Williams S, Somberg JC. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. Am J Cardiol. 1985 Nov 15; 56(13):877-81. PMID: 2414983.
      View in: PubMed
    252. Torres V, Flowers D, Somberg J. The clinical significance of polymorphic ventricular tachycardia provoked at electrophysiologic testing. Am Heart J. 1985 Jul; 110(1 Pt 1):17-24. PMID: 4013979.
      View in: PubMed
    253. Torres V, Flowers D, Somberg JC. The arrhythmogenicity of antiarrhythmic agents. Am Heart J. 1985 May; 109(5 Pt 1):1090-7. PMID: 3993517.
      View in: PubMed
    254. Miura DS, Keren G, Torres V, Butler B, Aogaichi K, Somberg JC. Antiarrhythmic effects of cibenzoline. Am Heart J. 1985 Apr; 109(4):827-33. PMID: 3984837.
      View in: PubMed
    255. Somberg JC, Butler B, Torres V, Tepper D, Keren G, Siegel L, Jentzer J, Miura DS. Therapy for late post infarction ventricular tachycardia. Angiology. 1985 Mar; 36(3):181-90. PMID: 3896040.
      View in: PubMed
    256. Somberg J, Tepper D, Wynn J. Prolonged repolarization: a historical perspective. Am Heart J. 1985 Feb; 109(2):395-8. PMID: 3966368.
      View in: PubMed
    257. Somberg J, Butler B, Flowers D, Tepper D, Torres V. Long term lorcainide therapy guided by electrophysiology studies. Acta Cardiol. 1985; 40(6):621-36. PMID: 3879419.
      View in: PubMed
    258. Flowers D, O'Gallagher D, Torres V, Miura D, Somberg JC. Flecainide: long-term treatment using a reduced dosing schedule. Am J Cardiol. 1985 Jan 01; 55(1):79-83. PMID: 3966401.
      View in: PubMed
    259. Somberg J. Antiarrhythmic drug therapy. Recent advances and current status. Cardiology. 1985; 72(5-6):329-48. PMID: 2866841.
      View in: PubMed
    260. Somberg J, Torres V, Flowers D, Miura D, Butler B, Gottlieb S. Prolongation of QT interval and antiarrhythmic action of bepridil. Am Heart J. 1985 Jan; 109(1):19-27. PMID: 3871296.
      View in: PubMed
    261. Somberg J, Butler B, Flowers D, Keefe D, Torres V, Miura D. Long-term lorcainide therapy in patients with ventricular tachycardia. Am Heart J. 1985 Jan; 109(1):33-40. PMID: 3966330.
      View in: PubMed
    262. Torres V, Flowers D, Miura D, Somberg J. Intravenous quinidine by intermittent bolus for electrophysiologic studies in patients with ventricular tachycardia. Am Heart J. 1984 Dec; 108(6):1437-42. PMID: 6507239.
      View in: PubMed
    263. Keren G, Tepper D, Butler B, Torres V, Somberg JC. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog. Am Heart J. 1984 Nov; 108(5):1236-43. PMID: 6333809.
      View in: PubMed
    264. Keren G, Tepper D, Butler B, Miura D, Aogaichi K, Somberg J. The efficacy of cibenzoline in preventing PES induction of ventricular tachycardia in the dog. J Clin Pharmacol. 1984 Oct; 24(10):466-72. PMID: 6511989.
      View in: PubMed
    265. Somberg JC, Torres V. New directions in antiarrhythmic drug therapy: the development of a promising new agent, lorcainide. Am J Cardiol. 1984 Aug 13; 54(4):1B. PMID: 6465042.
      View in: PubMed
    266. Somberg JC. New directions in antiarrhythmic drug therapy. Am J Cardiol. 1984 Aug 13; 54(4):8B-17B. PMID: 6147082.
      View in: PubMed
    267. Somberg JC, Butler B, Flowers D, Tepper D, Maguire W, Willens H, Keren G, Miura D. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):49B-54B. PMID: 6465047.
      View in: PubMed
    268. Somberg JC, Butler B, Flowers D, Keefe D, Torres V, Miura D. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):43B-48B. PMID: 6465046.
      View in: PubMed
    269. Somberg JC, Butler B, Torres V, Flowers D, Tepper D, Keefe D, Miura DS. Lorcainide therapy for the high-risk patient post myocardial infarction. Am J Cardiol. 1984 Aug 13; 54(4):37B-42B. PMID: 6465045.
      View in: PubMed
    270. Somberg JC, Butler B, Torres V, Flowers D, Tepper D, Wynn J, Keren G, Miura DS. Antiarrhythmic action of bethanidine. Am J Cardiol. 1984 Aug 01; 54(3):343-6. PMID: 6465015.
      View in: PubMed
    271. Somberg JC. New approaches to drug selection and serial drug testing. J Clin Pharmacol. 1984 Jul; 24(7):320-7. PMID: 6207209.
      View in: PubMed
    272. Keren G, Miura DS, Somberg JC. Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate. Am Heart J. 1984 Apr; 107(4):638-43. PMID: 6702556.
      View in: PubMed
    273. Brazzell RK, Aogaichi K, Heger JJ, Somberg JC, Carliner NH, Morganroth J. Cibenzoline plasma concentration and antiarrhythmic effect. Clin Pharmacol Ther. 1984 Mar; 35(3):307-16. PMID: 6697638.
      View in: PubMed
    274. Spivack C, Gottlieb S, Miura DS, Somberg JC. Flecainide toxicity. Am J Cardiol. 1984 Jan 15; 53(2):329-30. PMID: 6695731.
      View in: PubMed
    275. Somberg JC, Knox SM, Miura DS. Effect of quinidine on differing sensitivities of Purkinje fibers and myocardium to inhibition of monovalent cation transport by digitalis in dogs. Am J Cardiol. 1983 Nov 01; 52(8):1123-6. PMID: 6637835.
      View in: PubMed
    276. Somberg JC, Bounous H, Cagin N, Levitt B. Histamine antagonists as antiarrhythmic agents in ouabain cardiotoxicity in the cat. J Pharmacol Exp Ther. 1980 Aug; 214(2):375-80. PMID: 6104726.
      View in: PubMed
    277. Somberg JC, Bounous H, Levitt B. The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected cat. Eur J Pharmacol. 1979 Feb 15; 54(1-2):161-6. PMID: 421737.
      View in: PubMed
    278. Cagin NA, Benda R, Somberg J, Levitt B. Refractory heart failure. Comparison of time course of action of sublingual nitroglycerin and isosorbide dinitrate, oral or sublingual. N Y State J Med. 1978 May; 78(6):888-9. PMID: 418364.
      View in: PubMed
    279. Levitt B, Cagin N, Kleid J, Somberg J, Gillis R. Role of the nervous system in the genesis of cardiac rhythm disorders. Am J Cardiol. 1976 Jun; 37(7):1111-3. PMID: 1274874.
      View in: PubMed
    280. Levitt B, Cagin NA, Somberg JC, Kleid JJ. Neural basis for the genesis and control of digitalis arrhythmias. Cardiology. 1976; 61(1):50-60. PMID: 975124.
      View in: PubMed
    281. Cagin NA, Somberg J, Bounous H, Mittag T, Raines A, Levitt B. The influence of spinal cord transection on the capacity of digitoxin to induce cardiotoxicity. Arch Int Pharmacodyn Ther. 1974 Feb; 207(2):340-7. PMID: 4827418.
      View in: PubMed
    Somberg's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description